XTX Topco’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-76,068
Closed -$212K 4303
2026
Q1
$212K Buy
76,068
+61,635
+427% +$209K ﹤0.01% 2803
2025
Q4
$52.8K Buy
+14,433
New +$41.1K ﹤0.01% 2815
2025
Q3
Sell
-22,791
Closed -$42.4K 2773
2025
Q2
$42.4K Buy
+22,791
New +$39.5K ﹤0.01% 2046
2025
Q1
Sell
-30,619
Closed -$62K 2604
2024
Q4
$62K Buy
+30,619
New +$55.5K 0.01% 1860

Other funds holding FBIO

XTX Topco's FBIO Position: Q2 2026 in Review

XTX Topco sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 76,068 shares — an estimated $212K sold.

XTX Topco first reported a position in FBIO in Q4 2024 and held it in 4 quarters. The position peaked at $212K in Q1 2026. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • XTX Topco reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 76,068 Fortress Biotech shares in Q2 2026, an estimated $212K.
  • XTX Topco first reported a position in Fortress Biotech in Q4 2024 and held it in 4 quarters.
  • XTX Topco's Fortress Biotech position peaked at $212K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.